Relationship Between Exposure to Sunitinib and Efficacy and Tolerability Endpoints in Patients with Cancer: Results of a Pharmacokinetic/Pharmacodynamic Meta-analysis Publication Relationship Between Exposure to Sunitinib and Efficacy and Tolerability Endpoints in Patients with Cancer: Results of a Pharmacokinetic/Pharmacodynamic Meta-analysis In this pharmacokinetic/pharmacodynamic meta-analysis, we investigated relationships between clinical endpoints and sunitinib exposure in patients…Certara2010 年 7 月 1 日
Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation Publication Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation Understanding the potential for cytochrome P450-mediated drug-drug interactions (DDIs) is a critical step in the drug discovery process. DDIs…Certara2010 年 6 月 1 日
Concentration–Effect Relationships for the Drug of Abuse—γ-hydroxybutyric Acid Publication Concentration–Effect Relationships for the Drug of Abuse—γ-hydroxybutyric Acid γ-Hydroxybutyric acid (GHB) is an endogenous neurotransmitter that is abused because of its sedative/hypnotic and…Certara2010 年 6 月 1 日
Pharmacology and Safety of Glycerol Phenylbutyrate in Healthy Adults and Adults with Cirrhosis Publication Pharmacology and Safety of Glycerol Phenylbutyrate in Healthy Adults and Adults with Cirrhosis Phenylbutyric acid (PBA), which is approved for treatment of urea cycle disorders (UCDs) as sodium…Certara2010 年 6 月 1 日
Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-based Simulator Publication Identification of Cytochrome P450 Isoforms Involved in the Metabolism of Paroxetine and Estimation of Their Importance for Human Paroxetine Metabolism Using a Population-based Simulator We identify here for the first time the low-affinity cytochrome P450 (P450) isoforms that metabolize…Certara2010 年 3 月 1 日
A Semi-mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance Publication A Semi-mechanistic Model to Predict the Effects of Liver Cirrhosis on Drug Clearance Liver cirrhosis is characterized by a decrease in functional hepatocytes, lowered circulating levels of plasma…Certara2010 年 3 月 1 日
The Use of Biosimulation in the Design of a Novel Multilevel Weight Loss Maintenance Program for Overweight Children Publication The Use of Biosimulation in the Design of a Novel Multilevel Weight Loss Maintenance Program for Overweight Children Weight loss outcomes achieved through conventional behavior change interventions are prone to deterioration over time.…Certara2010 年 2 月 18 日
Prediction of Vss from In Vitro Tissue Binding Studies Publication Prediction of Vss from In Vitro Tissue Binding Studies To predict volume of distribution at steady-state (Vss), empirical (e.g., allometry) and mechanistic (using physicochemical…Certara2010 年 1 月 1 日
Population Pharmacokinetics of Teduglutide Following Repeated Subcutaneous Administrations in Healthy Participants and in Patients with Short Bowel Syndrome and Crohn’s Disease Publication Population Pharmacokinetics of Teduglutide Following Repeated Subcutaneous Administrations in Healthy Participants and in Patients with Short Bowel Syndrome and Crohn’s Disease Teduglutide is a GLP-2 analog currently evaluated for the treatment of short bowel syndrome, Crohn's…Certara2010 年 1 月 1 日
Prediction of Human Drug and Drug Interactions from Time-dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-based Simulator Publication Prediction of Human Drug and Drug Interactions from Time-dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-based Simulator Time-dependent inactivation (TDI) of human cytochromes P450 3A4 (CYP3A4) is a major cause of clinical…Certara2009 年 12 月 1 日